Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis

Abstract

Breast cancer (BC) is the most common cancer type in women and the second leading cause of death. Despite recent advances, the mortality rate of BC is still high, highlighting a need to develop new treatment strategies including the modulation of the immune system and immunotherapies. In this regard, understanding the complex function of the involved immune cells and their crosstalk with tumor cells is of great importance. T-cells are recognized as the most important cells in the tumor microenvironment and are divided into several subtypes including helper, cytotoxic, and regulatory T-cells according to their transcription factors, markers, and functions. This article attempts to provide a comprehensive review of the role of T-cell subsets in the prognosis and treatment of patients with BC, and crosstalk between tumor cells and T-cells. The literature overwhelmingly contains controversial findings mainly due to the plasticity of T-cell subsets within the inflammatory conditions and the use of different panels for their phenotyping. However, investigating the role of T-cells in BC immunity depends on a variety of factors including tumor types or subtypes, the stage of the disease, the localization of the cells in the tumor tissue and the presence of different cells or cytokines.

Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells

“…It is pertinent to note that, although the literature emphasizes the immunosuppressive role of TAMs [16], tumor-associated macrophages can have quite diverse phenotypes and functions, and in some cases, they may play an anti-tumoral role [27]. It is worth noting the same functional ambivalence can be applied to T lymphocytes, which, in addition to anti-tumoral roles, can act as immunosuppressors, particularly when exhibiting a regulatory T lymphocyte phenotype, impeding effective anti-tumoral responses [28].…”

Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities

“…Conversely, Tregs function as immunosuppressive cells, dampening the body's anti-tumour immune response and thereby fostering the progression of BC. 76 Enhancing the specific targeting of exosomes to T lymphocytes has been a challenging task. Interestingly, recent advances in BC research have shed light on this issue.…”

“…Among these, CD4+ T cells and CD8+ T cells predominantly exert anti‐tumour effects in BC. Conversely, Tregs function as immunosuppressive cells, dampening the body's anti‐tumour immune response and thereby fostering the progression of BC 76 …”

Natural products as promising modulators of breast cancer immunotherapy

“…TILs have different functions and transcription factors, and occur as several subtypes, including Th cells (helper cells), CTLs (cytotoxic CD8+ T lymphocytes), and Tregs (regulatory T-cells). Other cells with a role in immune regulation are CD4+ effector T cells, tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), DCs, NKs, and mast cells ( 11 ). Several immunosuppressive factors, such as prostaglandin E2 (PGE2), interleukin-10 (IL-10), and transforming growth factor-β (TGF-β), are secreted by these cells to regulate the immunosuppressive network ( 5 ).…”